[Foundation of pharmaceutical policy in the Federation of Bosnia-Herzegovina]. 1998

S Lucić, and D Nenadić
Ministarstvo zdravstva Federacije BiH, Sarajevo.

Pharmaceuticals are inevitable domain of disease prevention, diagnostics and treatment. The basic objective of pharmaceutical sector reform is to meet the needs of the majority of the population with the essential pharmaceuticals, which are proven as effective, evaluated quality and affordable prices. That objective could be achieved by undertaking a range of measures within the national pharmaceutical policy as an integral part of the overall health, policy in the country. Key elements of that policy should be: pharmaceutical management at the level of the Federal Ministry of Health and cantonal ministrie of health, pharmaceutical legislative documents, rationalization of pharmaceutical therapy (choices of essential pharmaceuticals, choices of pharmaceuticals covered by the resources of health insurance funds, list of hospital pharmaceuticals, selections during pharmaceuticals registration, educational measures, surveillance of measures), spreading information on pharmaceuticals by the pharmaceutical information centre, pharmaceutical supply (local pharmaceutical production, pharmaceuticals import, humanitarian assistance), funding of pharmaceuticals costs (cantonal and hospital lists of pharmaceuticals,) other reform strategies (quality control of pharmaceuticals, surveillance of side-effects, role of pharmacists in health system, environment protection) and strengthening of inspector surveillance.

UI MeSH Term Description Entries
D010593 Pharmaceutical Services Total pharmaceutical services provided by qualified PHARMACISTS. In addition to the preparation and distribution of medical products, they may include consultative services provided to agencies and institutions which do not have a qualified pharmacist. Pharmaceutic Services,Pharmaceutical Care,Pharmacy Services,Services, Pharmaceutic,Services, Pharmaceutical,Services, Pharmacy,Care, Pharmaceutical,Pharmaceutic Service,Pharmaceutical Service,Pharmacy Service,Service, Pharmaceutic,Service, Pharmaceutical,Service, Pharmacy
D004364 Pharmaceutical Preparations Drugs intended for human or veterinary use, presented in their finished dosage form. Included here are materials used in the preparation and/or formulation of the finished dosage form. Drug,Drugs,Pharmaceutical,Pharmaceutical Preparation,Pharmaceutical Product,Pharmaceutic Preparations,Pharmaceutical Products,Pharmaceuticals,Preparations, Pharmaceutical,Preparation, Pharmaceutical,Preparations, Pharmaceutic,Product, Pharmaceutical,Products, Pharmaceutical
D006291 Health Policy Decisions, usually developed by government policymakers, for determining present and future objectives pertaining to the health care system. Health Care Policies,Health Policies,Healthcare Policy,National Health Policy,Care Policies, Health,Health Care Policy,Health Policy, National,Healthcare Policies,National Health Policies,Policies, Health,Policies, Health Care,Policies, Healthcare,Policy, Health,Policy, Health Care,Policy, Healthcare
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D017522 Bosnia and Herzegovina A country of eastern Europe, formerly the province of Bosnia in Yugoslavia, uniting with the province of Herzegovina to form the Republic of Bosnia and Herzegovina in 1946. It was created 7 April 1992 as a result of the division of Yugoslavia and recognized by the United States as an independent state. Bosnia takes is name from the river Bosna, in turn from the Indoeuropean root bhog, "current"; Herzegovina is from the Serbian herceg (duke) + -ov (the possessive) + -ina (country or territory). Bosnia and Hercegovina,Bosnia-Herzegovina,Bosnia
D017850 Economics, Pharmaceutical Economic aspects of the fields of pharmacy and pharmacology as they apply to the development and study of medical economics in rational drug therapy and the impact of pharmaceuticals on the cost of medical care. Pharmaceutical economics also includes the economic considerations of the pharmaceutical care delivery system and in drug prescribing, particularly of cost-benefit values. (From J Res Pharm Econ 1989;1(1); PharmacoEcon 1992;1(1)) Pharmaceutical Economics,Pharmacoeconomics,Pharmacy Economics,Economic, Pharmacy,Economics, Pharmacy,Pharmacy Economic
D018166 Health Care Reform Innovation and improvement of the health care system by reappraisal, amendment of services, and removal of faults and abuses in providing and distributing health services to patients. It includes a re-alignment of health services and health insurance to maximum demographic elements (the unemployed, indigent, uninsured, elderly, inner cities, rural areas) with reference to coverage, hospitalization, pricing and cost containment, insurers' and employers' costs, pre-existing medical conditions, prescribed drugs, equipment, and services. Healthcare Reform,Health Care Reforms,Healthcare Reforms,Reform, Health Care,Reform, Healthcare,Reforms, Health Care,Reforms, Healthcare

Related Publications

S Lucić, and D Nenadić
June 2018, Materia socio-medica,
S Lucić, and D Nenadić
January 2001, Journal of perinatal medicine,
S Lucić, and D Nenadić
January 2000, Medicinski arhiv,
S Lucić, and D Nenadić
September 2021, Acta informatica medica : AIM : journal of the Society for Medical Informatics of Bosnia & Herzegovina : casopis Drustva za medicinsku informatiku BiH,
S Lucić, and D Nenadić
February 2007, European journal of public health,
S Lucić, and D Nenadić
September 2011, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin,
S Lucić, and D Nenadić
June 1999, Croatian medical journal,
S Lucić, and D Nenadić
January 1999, Medicinski arhiv,
S Lucić, and D Nenadić
August 2010, Croatian medical journal,
Copied contents to your clipboard!